Recommended Topic Related To:

Photofrin

"The U.S. Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing "...

Photofrin

PATIENT INFORMATION

Photosensitivity

Patients should be warned to avoid exposure of skin and eyes to direct sunlight or bright indoor light for at least 30 days following injection with PHOTOFRIN (porfimer sodium) .

Patients should be informed that photosensitivity might last for more than 90 days if patients suffer from liver impairment.

Patients should be instructed to wear protective clothing and dark sunglasses when outdoors, which have an average white light transmittance of < 4%.

Patients should be encouraged to expose their skin to ambient indoor light to facilitate elimination of PHOTOFRIN (porfimer sodium) from their skin.

Common Adverse Reactions

Patients should be informed that treatment with photodynamic therapy might lead to adverse reactions which include ocular sensitivity, chest pain, respiratory distress or esophageal strictures. In such cases, patients should call their physicians.

Last reviewed on RxList: 5/19/2011
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.